AstraZeneca PLC Lung Cancer Pill May Get Second Chance After Tests

November 21, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Nov 20 (Reuters) - The lung cancer pill Iressa has shown surprising results for patients with advanced disease where it has been at least as effective as a standard chemotherapy treatment, researchers reported on Thursday.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory

AstraZeneca Pharmaceuticals LP